reflection objectives: Oral appliances (OAs) are considered to be a treatment option for patients with obstructive drowse apnea/hypopnea syndrome (OSAHS).

reflection objectives: Oral appliances (OAs) are considered to be a treatment option for patients with obstructive drowse apnea/hypopnea syndrome (OSAHS). Although the effectiveness of these appliances has been evaluated in a number of clinical trials, there are hardly any follow-up studies concerning the dental and skeletal side imports that, theoretically, could be caused by way of OAs. We sought to examine the long-term skeletal and occlusal consequences of a nocturnally worn activator in adult patients treated for OSAHS.

Design: We analyzed the dental casts and lateral radiographs of 34 patients (mean age, 529 years; SD 96 years; range, 271 to 646 years) before initiating treatment and after at least 24 month of treatment (mean continuance of treatment, 29.6 months; range, 241 to 435 months; SD 51 months) The OA was worn by the agency of each patient 6 to 8 h nightly for > 5 days for week.

Setting: Department of Orthodontics, Dental Medical institute Freiburg, Germany.

Measurements and results: Follow-up polysomnography studies confirmed improved breathing parameters with the use of OAs. A statistically significant alteration in the occlusion was rest The anteroposterior position of the molars and the inclination of the upper and lower incisors were changed. No skeletal changes in the position of the mandible were noted.

Conclusions: The data allude to that in addition to regulate polysomnographic examinations, regular dental follow-up visits are mandatory when lifelong OSAHS treatment with an OA is being considered for patients with obstructive lie in the grave apnea/hypopnea.

Key words: mandibular advancement devices; oral appliances; side effects; lie in the grave apnea; snoring; treatment

Abbreviations: CPAP = continuous positive airway pressure; OA = oral appliance; OSAHS = obstructive nap apnea/hypopnea syndrome

**********

Obstructive be still apnea/hypopnea syndrome (OSAHS) is caused at the periodic reduction or cessation of airflow suitable to narrowing or occlusion of the upper airway during rest Continuous positive airway pressure (CPAP) therapy is indicated when the respiratory disturbance index surpasss 30 events per hour. A respiratory disturbance index of > 5 incidents per hour should be considered for treatment if it is associated with typical clinical symptoms like daytime sleepiness and/or cardiovascular disease. (1) A lately published study (2) has intimateed an elevated risk of developing cardiovascular disease flat when sleep-related breathing disorders of cheap intensity are present. Accordingly, treatment might equal be indicated in nonsleepy patients with mild nocturnal apneas/hypopneas. (3) In several studies, (45) oral appliances (OAs) have been shown to improve OSAHS symptoms and objectively measured breathing parameters in picked obstructive sleep apnea patients and are considered to be an additional treatment approach. In these patients, especially in young patients with mild OSAHS, compliance might be higher with OA therapy than with conventional CPAP therapy. (67)

For the mostly part, the design of OAs is derived from functional orthodontic devices. To maintain the patency of the pharyngeal airway and to hinder the lumen from collapsing during rest (8,9) the appliances hold the mandible in a forward and vertically make opened position. OAs are anchored mainly forward the dentition rather than the mucosa to make sure retention, thus, the teeth are loaded with permanent forces when the device is worn at night. (1011)

Patients with OSAHS treated according to OAs need to use the device onward a long-term basis to interrupt the recurrence of symptoms. It is thus important to clarify the potential adverse efficiencys of OA treatment on the dentition, occlusion, and skeletal changes in adults after long-term nocturnal use of the OAs throughout a period of at least 24 months

MATERIALS AND METHODS

We retrospectively analyzed the dental casts and lateral head plates taken before the start of treatment and thereafter at a mean of 296 month (SD 51 months; range, 241 to 435 months) Thirty-four otherwise healthy patients with mild-to-moderate OSAHS were enlisted in the study. The patients' ages ranged from 271 to 646 years (mean age, 529 years; SD 96 years), and the mean dead body mass index was increased at 286 kg/[msup2] (SD 42 kg/[msup2]) The diagnosis and the extent of severity of obstructive nap apnea were established by polysomnography. The patients either did not tolerate CPAP and/or they refused to use it upon a long-term basis. They were therefore giveed OA treatment instead. According to our treatment regime, patients were treated with an OA and were included in this follow-up analysis if the succes of their treatment with an OA had been confirmed by dint of control polysomnography that had been carried revealed 4 months (SD, 1.2) after the OA emplacement.

barely those patients were included into the subject of attention who had given us convincing assurance that the device had been worn upon a regular basis for at least 6 to 8 h by night for > 5 nights by week during the study period. Patients with fewer than 10 healthy teeth in each jaw, or those with active dental or periodontal disease and/or bitter temporomandibular joint dysfunction at the time of the baseline investigation were exclud from this long-term assessment. The patients accepted into the subject of attention were subjected to a standardized clinical and dental examination before treatment and at the follow-up appointment. These examinations included the use of lateral cephalometric radiography in habitual occlusion and dental cast analysis. The intermaxillary relationship between the upper and lower dental arches was recorded with a wax registration in replete occlusion.

...